Cardioprotective Effect of Intravenous Nicorandil in Patients With Successful Reperfusion for Acute Myocardial Infarction

Authors:

Abstract
This study was designed to assess the cardioprotective effect of intravenous nicorandil, a potassium channel opener, in preventing reperfusion injury in acute myocardial infarction. Seventy patients were treated with placebo or nicorandil concomitant with reperfusion therapy in a prospective, randomized, double-blind fashion within 6 h after the onset of acute myocardial infarction. Nicorandil was administered before reperfusion as a 2-mg boIus iv injection followed by continuous infusion of 2-6 mg/h for the next 3 h. Thirty-six patients (17 in the placebo group, 19 in the nicorandil group) who demonstrated both complete occlusion of an infarct-related vessel before treatment and successful reperfusion were included in the final analysis. No significant changes in left ventricular ejection fraction were observed between the immediate and chronic phases in each group. In the analysis of regional ventricular function, the placebo group did not show any significant change in regional chord shortening (26.8±8.2 vs 24.3±7.3%, NS) or hypocontractile perimeter (36.4±28.2% vs 28.3±24.8%, NS) between immediate and chronic phase left ventriculograms. In contrast, in the nicorandil group, a significant increase in regional chord shortening (21.5±11.0% vs 25.8±11.3%, pJpn Circ J 1998; 62: 183 - 189)

This publication has 28 references indexed in Scilit: